# Schema Therapy for Treatment-resistant Anxiety Disorders

> **NCT06298695** · NA · NOT_YET_RECRUITING · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 172 (estimated)

## Conditions studied

- Anxiety Disorders

## Interventions

- **BEHAVIORAL:** Individual Schema Therapy
- **OTHER:** TAU

## Key facts

- **NCT ID:** NCT06298695
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2030-12-31
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06298695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06298695, "Schema Therapy for Treatment-resistant Anxiety Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06298695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*